BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Prognosis
23 results:

  • 1. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine tumors.
    Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
    Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CircCDK14 Promotes tumor Progression and Resists Ferroptosis in Glioma by Regulating PDGFRA.
    Chen S; Zhang Z; Zhang B; Huang Q; Liu Y; Qiu Y; Long X; Wu M; Zhang Z
    Int J Biol Sci; 2022; 18(2):841-857. PubMed ID: 35002529
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Colorectal paragangliomas with immunohistochemical deficiency of succinate dehydrogenase subunit B.
    Kimura N; Ishikawa M; Shigematsu K
    Endocr J; 2022 May; 69(5):523-528. PubMed ID: 34853215
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
    Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
    BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Epigenetic and metabolic reprogramming of SDH-deficient paragangliomas.
    Moog S; Lussey-Lepoutre C; Favier J
    Endocr Relat Cancer; 2020 Dec; 27(12):R451-R463. PubMed ID: 33112834
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Performance of Gene Expression Profile Tests for prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis.
    Marchetti MA; Coit DG; Dusza SW; Yu A; McLean L; Hu Y; Nanda JK; Matsoukas K; Mancebo SE; Bartlett EK
    JAMA Dermatol; 2020 Sep; 156(9):953-962. PubMed ID: 32745161
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. An Open-Label Study of the Safety and Efficacy of Tag-7 Gene-Modified tumor cells-Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal cell Cancer.
    Novik AV; Danilova AB; Sluzhev MI; Nehaeva TL; Larin SS; Girdyuk DV; Protsenko SA; Semenova AI; Danilov AO; Moiseyenko VM; Georgiev GP; Baldueva IA
    Oncologist; 2020 Sep; 25(9):e1303-e1317. PubMed ID: 32240562
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Vascular architecture mapping for early detection of glioblastoma recurrence.
    Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
    Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Elevated Endogenous sdha Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma.
    Chattopadhyay C; Oba J; Roszik J; Marszalek JR; Chen K; Qi Y; Eterovic K; Robertson AG; Burks JK; McCannel TA; Grimm EA; Woodman SE
    Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4187-4195. PubMed ID: 31596927
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study.
    Yuen C; Reid P; Zhang Z; Soliven B; Luke JJ; Rezania K
    J Immunother; 2019 Apr; 42(3):94-96. PubMed ID: 30614917
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
    Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
    J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Long-term prognosis of patients with pediatric pheochromocytoma.
    Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
    Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments.
    Papathomas TG; de Krijger RR; Tischler AS
    Semin Diagn Pathol; 2013 Aug; 30(3):207-23. PubMed ID: 24144290
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
    Gill AJ
    Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hereditary paragangliomas.
    Raygada M; Pasini B; Stratakis CA
    Adv Otorhinolaryngol; 2011; 70():99-106. PubMed ID: 21358191
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Histologically confirmed intracranial germ cell tumors; an analysis of 62 patients in a single institute.
    Lee D; Suh YL
    Virchows Arch; 2010 Sep; 457(3):347-57. PubMed ID: 20652714
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Management of primary intracranial germ cell tumors.
    Kyritsis AP
    J Neurooncol; 2010 Jan; 96(2):143-9. PubMed ID: 19588227
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Alpha-FP normalization as a prognostic factor for mediastinal origin embryonal carcinoma: report of five cases.
    Murakawa Y; Satake N; Kato S; Yosioka T; Kanamaru R
    Intern Med; 2002 Oct; 41(10):883-8. PubMed ID: 12413016
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
    Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
    Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.